These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7615162)

  • 21. Fibrinolysis--a review.
    Kane KK
    Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of urokinase on the proliferation of primary cultures of human prostatic cells.
    Kirchheimer JC; Wojta J; Hienert G; Christ G; Heger ME; Pflüger H; Binder BR
    Thromb Res; 1987 Nov; 48(3):291-8. PubMed ID: 2448891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
    Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
    Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Position and developmental trends in fibrinolytic therapy].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):6-17. PubMed ID: 2427416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiological consequences of loss of plasminogen activator gene function in mice.
    Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
    Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of argatroban-induced endogenous thrombolysis by PKSI-527, and antibodies to TPA and UPA, evaluated in a rat arterial thrombolysis model.
    Hashimoto M; Oiwa K; Matsuo O; Ueshima S; Okada K; Okada Y; Okamoto S; Giddings JC; Yamamoto J
    Thromb Haemost; 2003 May; 89(5):820-5. PubMed ID: 12719778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urokinase-dependent cell surface proteolysis and cancer.
    Blasi F; Verde P
    Semin Cancer Biol; 1990 Apr; 1(2):117-26. PubMed ID: 2151734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.
    Bugge TH; Flick MJ; Daugherty CC; Degen JL
    Genes Dev; 1995 Apr; 9(7):794-807. PubMed ID: 7705657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury.
    Lijnen HR
    Verh K Acad Geneeskd Belg; 2001; 63(6):605-22. PubMed ID: 11813512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
    Andreenko GV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmin, substilisin-like endoproteases, tissue plasminogen activator, and urokinase plasminogen activator are involved in activation of latent TGF-beta 1 in human seminal plasma.
    Chu TM; Kawinski E
    Biochem Biophys Res Commun; 1998 Dec; 253(1):128-34. PubMed ID: 9875232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.
    Fontaine V; Jacob MP; Houard X; Rossignol P; Plissonnier D; Angles-Cano E; Michel JB
    Am J Pathol; 2002 Nov; 161(5):1701-10. PubMed ID: 12414517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-type plasminogen activator.
    Lijnen HR; Collen D
    Ann Biol Clin (Paris); 1987; 45(2):198-201. PubMed ID: 2956911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary defects in fibrinolysis associated with thrombosis.
    Hong JJ; Kwaan HC
    Semin Thromb Hemost; 1999; 25(3):321-31. PubMed ID: 10443962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of plasminogen-plasmin system in cancer.
    Kwaan HC; McMahon B
    Cancer Treat Res; 2009; 148():43-66. PubMed ID: 19377918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A complex, tissue-specific role for plasmin and its regulators in modulating fibrogenic activity.
    Cosgrove D
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F10-1. PubMed ID: 17494093
    [No Abstract]   [Full Text] [Related]  

  • 39. Profibrinolytic and antifibrinolytic effects of platelets.
    Devine DV; Carter CJ
    Coron Artery Dis; 1995 Dec; 6(12):915-22. PubMed ID: 8723012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enzymatic fibrinolytic agents].
    Jamet M; Granthil C; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):693-6. PubMed ID: 31112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.